Abstract
The present invention relates to novel glucofuranose esters and glucopyranose esters of alkyl-fumarates. The esters are suitable for use as active substances in the treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune
disorders.
disorders.
Original language | English |
---|---|
Patent number | WO 2007/006308 Al |
Priority date | 7/7/05 |
Filing date | 7/7/06 |
Publication status | Published - Jan 18 2007 |